Becca Flitter

6PUBLICATIONS
61CO-AUTHORS
Molecular targetsPreventative health careInnate immunityAgricultural molecular engineering of nucleic acids and proteinsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 14, 2025
An oral norovirus vaccine generates mucosal immunity and reduces viral shedding in a phase 2 placebo-controlled challenge study.

Becca A Flitter, Joshua Gillard, Susan N Greco

|Mar 05, 2025
An oral norovirus vaccine tablet was safe and elicited mucosal immunity in older adults in a phase 1b clinical trial.

Becca A Flitter, Susan N Greco, Colin A Lester

|Mar 05, 2025
Broadly neutralizing antibodies targeting pandemic GII.4 variants or seven GII genotypes of human norovirus.

Juyeon Park, Lisa C Lindesmith, Adam S Olia

|Feb 24, 2024
A Next-Generation Adenoviral Vaccine Elicits Mucosal and Systemic Immunogenicity and Reduces Viral Shedding after SARS-CoV-2 Challenge in Nonhuman Primates.

Sarah N Tedjakusuma, Colin A Lester, Elena D Neuhaus

|Apr 23, 2022
Drop the Needle; A Temperature Stable Oral Tablet Vaccine Is Protective against Respiratory Viral Pathogens.

Becca A Flitter, Molly R Braun, Sean N Tucker

|Jul 20, 2021
PGD2 and CRTH2 counteract Type 2 cytokine-elicited intestinal epithelial responses during helminth infection.

Oyebola O Oyesola, Michael T Shanahan, Matt Kanke

Pageof 1

Frequent Collaborators

3 joint publications

Sean N Tucker

2 joint publications

Ralph S Baric

2 joint publications

James F Cummings

2 joint publications

Marcela F Pasetti